Intermountain BMT

Salt Lake City, Utah 84143

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia

Studies at this site

• A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) — Completed